This content is only for use by healthcare professionals.

By continuing to view this content, you are confirming that you are a healthcare professional.

Key Opinion

Rethinking combination therapy: what the latest nephrology evidence shows

  • Diagnostic imaging workflows
  • Assay reproducibility
  • Data normalization

Date Published:

Abstract

From a workflow perspective, early intervention correlates with better long-term outcomes, with meaningful differences between subgroups. In routine practice, patient selection criteria deserve closer scrutiny, pending validation in prospective studies. According to consensus recommendations, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, although confirmatory data are still limited. In routine practice, cost considerations continue to shape adoption in smaller units, a finding echoed by several independent groups. Across multiple cohorts, early intervention correlates with better long-term outcomes, particularly in resource-constrained settings.

From a workflow perspective, threshold harmonization is still an open question, pending validation in prospective studies. Contrary to earlier assumptions, patient selection criteria deserve closer scrutiny, a finding echoed by several independent groups. Contrary to earlier assumptions, threshold harmonization is still an open question, particularly in resource-constrained settings. Recent studies suggest that real-world registries complement randomized trial evidence, a finding echoed by several independent groups.

In routine practice, early intervention correlates with better long-term outcomes, as discussed in the accompanying commentary. Longitudinal data show that patient selection criteria deserve closer scrutiny, which has direct implications for daily practice. Longitudinal data show that training and accreditation are decisive for reproducibility, although confirmatory data are still limited.

Emerging evidence indicates that threshold harmonization is still an open question, as discussed in the accompanying commentary. Contrary to earlier assumptions, threshold harmonization is still an open question, and this trend is expected to continue. Emerging evidence indicates that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, although confirmatory data are still limited. Longitudinal data show that variability between operators remains a key limitation, with meaningful differences between subgroups. In routine practice, standardized reporting improves comparability between centers, pending validation in prospective studies.

Longitudinal data show that early intervention correlates with better long-term outcomes, with meaningful differences between subgroups. Emerging evidence indicates that variability between operators remains a key limitation, and this trend is expected to continue.

In routine practice, cost considerations continue to shape adoption in smaller units, which has direct implications for daily practice. From a workflow perspective, digital tooling shortens time-to-decision considerably, a finding echoed by several independent groups. According to consensus recommendations, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups. Emerging evidence indicates that real-world registries complement randomized trial evidence, and this trend is expected to continue.

References

  1. Tanaka et al. Early screening programs. J Nephrology Res. 2023;10(1):952-1065.
  2. Okafor et al. Long-term disease management. J Nephrology Res. 2023;38(4):873-1092.
  3. Novak et al. Method validation. J Nephrology Res. 2024;32(9):383-1042.